Comparison of amoxicillinclavulanic acid high dose with cefdinir in the treatment of acute otitis media

Drugs

Volumn 72, Issue 15, 2012, Pages 1991-1997

  Casey, Janet R ^a   Block, Stan L ^b   Hedrick, Jim ^b   Almudevar, Anthony ^c   Pichichero, Michael E ^a,d  

^a Legacy Pediatrics   (United States)

^b Kentucky Pediatric Research Institute   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

Amoxicillinclavulanic acid; Cefdinir; Children; Otitis media

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFDINIR; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ACUTE OTITIS MEDIA; AGE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL ELECTRONIC MONITORING SYSTEM; MEDICAL SPECIALIST; MIDDLE EAR EFFUSION; MONITORING; MULTICENTER STUDY; OTOSCOPIST; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION PROCESS; ACUTE DISEASE; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION; FOLLOW UP; INFANT; OTITIS MEDIA; PROSPECTIVE STUDY; SINGLE BLIND PROCEDURE;

ACUTE DISEASE; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INFANT; OTITIS MEDIA; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84867288369     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/11590320-000000000-00000     Document Type: Article

References (11)

1. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 2004; 113: 1451-65
2. Casey JR, Block S, Puthoor P, et al. A simple scoring system to improve clinical assessment of acute otitis media. Clin Pediatr (Phila) 2011 Jul; 50 (7): 623-9
3. Block SL, McCarty JM, Hedrick JA, et al. Comparative safety and efficacy of cefdinir vs. amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J 2000; 19: S159-65 (Pubitemid 32001763)
4. Block SL, Busman TA, Paris MM, et al. Comparison of fiveday cefdinir treatment with ten-day low dose amoxicillin/clavulanate treatment for acute otitis media. Pediatr Infect Dis J 2004; 23 (9): 834-8 (Pubitemid 40221026)
5. Jacobs MR, Felmingham D, Appelbaum PC, et al. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003; 52 (2): 229-46 (Pubitemid 36986885)
6. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23: 824-8 (Pubitemid 40221024)
7. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23 (9): 829-33 (Pubitemid 40221025)
8. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2010; 29 (4): 304-9
9. Cifaldi MA, Paris MM, Devcich KJ, et al. Parent-reported outcomes for treatment of acute otitis media with cefdinir or amoxicillin/clavulanate oral suspensions. Pediatr Drugs 2004; 6 (6): 387-93 (Pubitemid 40065381)
10. Marchant CD, Carlin SA, Johnson CE, et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media; the "Pollyanna phenomenon." J Pediatr 1992; 120: 72-7
11. Arguedas A, Dagan R, Leibovitz E, et al.Amulticenter, open label, double tympanocentesis study of high dose cefdinir in children with acute otitis media at high risk of persistent or recurrrent infection. Pediatr Inf Dis J 2006; 25: 211-8 (Pubitemid 43379060)